grant Review committee

Within the SAB a Grant Review Committee reviews and makes recommendations on individual grant applications. The Committee conforms to the National Institutes of Health process, utilizing double-blind peer review. Members are drawn from the ranks of the Scientific Advisory Board, supplemented by peer reviewers with deep expertise in the scientific field proposed for study. The Grant Review Committee reviews every grant application, and makes recommendations to the LRA Board on individual grant approvals.

LRA’s Financial Review Committee
The Financial Review Committee of the SAB is composed of business leaders with extensive strategic, operational and senior management experience whose role is to bridge the gap between the research community and the marketplace with the goal of transitioning successful research programs into accessible treatments that are readily available to patients. Members of this Committee are:

Robert Kobre CPA, MBA. Kobre is Managing Director at Credit Suisse where he specializes in IPOs, leveraged loans, high yield bonds and M&A for equity clients. He has over 20 years of financial industry experience and advises clients in health care and numerous other industries. Kobre has advised LRA extensively during the past 5 years on research objectives, protocols and grant-making strategy.

Brian Scanlan is President of Mount Hope Capital, a family office based in Greenwich, CT.  Scanlan is the founder of Caminus Corporation (formerly ZaiNet Software, Inc), a NASDAQ-listed  energy software company based in New York.